Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

NIH 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 6Tumor-Agnostic 5Gynecologic 3Head & Neck 1

Conditions

Ovarian Neoplasms 328Fallopian Tube Neoplasms 153Carcinoma, Ovarian Epithelial 115Endometrial Neoplasms 95Uterine Cervical Neoplasms 80Neoplasms 28Breast Neoplasms 27Peritoneal Neoplasms 24Brenner Tumor 24Carcinoma, Non-Small-Cell Lung 21Stomach Neoplasms 18Recurrence 17Neoplasm Metastasis 14Uterine Neoplasms 13Testicular Neoplasms 11Parkinson Disease 4, Autosomal Dominant Lewy Body 11Colorectal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Lung Neoplasms 10Melanoma 9Testicular Germ Cell Tumor 8Central Nervous System Neoplasms 8Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Esophageal Neoplasms 7Carcinoma 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Neurotoxicity Syndromes 6Carcinosarcoma 6

Interventions

pembrolizumab 5Cisplatin 4Paclitaxel 3lenvatinib 2Fluorouracil 2trastuzumab deruxtecan 1sargramostim 1resiquimod 1poly ICLC 1oregovomab 1liposomal doxorubicin 1fluoroazomycin arabinoside 1fludarabine 1cemiplimab 1catumaxomab 1cabozantinib 1Therapeutics 1Therapeutic Irrigation 1TKM-080301 1Radiation, Ionizing 1Radiation 1Quality of Life 1Proctoscopy 1Prednisone 1Prednisolone 1Patient Reported Outcome Measures 1Papanicolaou Test 1Oxaliplatin 1Nelfinavir 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Adenocarcinoma × Paclitaxel × Gynecologic × Clear all
NCT04034251 2026-05-05

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
12 enrolled 18 charts
GastrointestinalGynecologic

Adenocarcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT01616303 2020-09-14

A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer

Quest PharmaTech Inc.

Phase 2 Completed
97 enrolled
Gynecologic

Adenocarcinoma, Neoplasms, Ovarian Neoplasms

NCT00001569 2008-03-04

Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
74 enrolled
Gynecologic

Adenocarcinoma, Carcinoma, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡